Hypertension and heart failure affect millions worldwide. Yet in many patients, doctors cannot fully explain why the heart ...

Researchers discover a gut-brain-heart axis where the bacterial metabolite IAA regulates hypocretin neurons to control heart ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...

A new study published in the journal of Frontiers in Cardiovascular Medicine revealed that Sodium-glucose cotransporter 2 ...

Pirfenidone is associated with fewer arrhythmic events and reduced diastolic dysfunction in patients with idiopathic pulmonary fibrosis.

Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk.

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can ...

Researchers from the laboratory of Dr. Sufansa Sawamiphak, head of the group for the study of cardiovascular-hematopoietic ...

As American Heart Month closes out, medical experts are putting the spotlight on a less publicized cardiovascular issue: ...

Many people at risk for heart failure remain stable over time, some worsen, but others improve as well. Blood tests and heart ...

The findings, published this month in Nature Cardiovascular Research, reveal a previously unknown link between immune ...

A modest modification of daily dietary habits resulted in a visible change within the human body in only two months. Research ...